Effects of lysed Enterococcus faecalis FK-23 on allergen-induced serum antibody responses and active cutaneous anaphylaxis in mice

Clinical and Experimental Allergy

Volumn 34, Issue 11, 2004, Pages 1784-1788

  Shimada, Takashi ^a,b,g   Cheng, L ^b,c   Yamasaki, A ^b   Ide, M ^a   Motonaga, C ^a   Yasueda, H ^d   Enomoto, K ^e   Enomoto, T ^f   Shirakawa, T ^b  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^c NANJING MEDICAL UNIVERSITY   (China)

^d SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f SUWA RED CROSS HOSPITAL   (Japan)

^g Nichinichi Pharmaceutical Co Ltd   (Japan)

Author keywords

Allergy; Cutaneous anaphylaxis; Cytokines; Enterococcus faecalis; Immunoglobulins; Lactic acid bacteria

Indexed keywords

ALLERGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 5; LYSED ENTEROCOCCUS FAECALIS FK 23; LYSOZYME; OVALBUMIN; POLLEN ANTIGEN; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCOCCUS FAECALIS; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN PRODUCTION; LACTIC ACID BACTERIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SKIN ANAPHYLAXIS; SPLEEN CELL;

ADMINISTRATION, ORAL; ALLERGENS; ANAPHYLAXIS; ANIMALS; ANTIGENS, BACTERIAL; CELLS, CULTURED; CRYPTOMERIA; CYTOKINES; ENTEROCOCCUS FAECALIS; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MURAMIDASE; POLLEN; SKIN TESTS; SPLEEN;

EID: 9244240734     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02092.x     Document Type: Article

References (27)

1. Berg RD. The indigenous gastrointestinal microflora. Trends Microb 1996; 4:430-5.
2. Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003; 3:15-20.
3. Bjoksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29:342-6.
4. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30:1590-6.
5. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-34.
6. Bjoksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516-20.
7. Fukuda S, Ishikawa H, Koga Y et al. Allergic symptoms and microflora in schoolchildren. J Adolesc Health 2004; 35:156-8.
8. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-10.
9. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9.
10. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-71.
11. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119-21.
12. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111:389-95.
13. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15:152-8.
14. Shimada T, Cheng L, Ide M, Fukuda S, Enomoto T, Shirakawa T. Effect of lysed Enterococcus faecalis FK-23 (LFK) on allergen-induced peritoneal accumulation of eosinophils in mice. Clin Exp Allergy 2003; 33:684-7.
15. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. J Invest Allergol Clin Immunol 2004, in press.
16. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria Japonica) pollen. J Allergy Clin Immunol 1983; 71:77-86.
17. Shida K, Hachimura S, Ametani A et al. Serum IgE response to orally ingested antigen: a novel IgE response model with allergen-specific T-cell receptor transgenic mice. J Allergy Clin Immunol 2000; 105:788-95.
18. Sudo N, Yu XN, Aiba Y et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002; 32:1112-6.
19. Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 2003; 33:1634-40.
20. Matricardi PM, Bjorksten B, Bonini S et al. Microbial products in allergy prevention and therapy. Allergy 2003; 58:461-71.
21. Shida K, Makino K, Morishita A et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998; 115:278-87.
22. Murosaki S, Yamamoto Y, Ito K et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol 1998; 102:57-64.
23. Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000; 30:1804-8.
24. Pessi T, Isolauri E, Sutas Y, Kankaanranta H, Moilanen E, Hurme M. Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Int Immunopharmacol 2001; 1:211-8.
25. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15:297-322.
26. Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002; 1:617-23.
27. Shida K, Takahashi R, Iwadate E et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002; 32:563-70.